+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 40Years - 65Years
All Genders
Healthy Volunteers
ID07729943

Evaluating Ginseng and Cordyceps Supplements for Aerobic Fitness, Lactate Processing, and Nitric Oxide in Adults Aged 40 to 65 Over 30 Days

Led by Applied Food Sciences Inc. · Updated on 2026-07-28

75

Participants Needed

1

Research Sites

5 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of Ginseng and Cordyceps supplements on aerobic capacity, lactate kinetics, and nitric oxide levels in healthy adults aged 40 to 65. This randomized, double-blind, placebo-controlled trial involves 75 participants and aims to assess potential benefits related to energy, recovery, mood, and quality of life over a 30-day period. Participants are randomly assigned to one of three groups receiving either 250 mg Panax Ginseng extract, 1 gram Cordyceps Militaris extract, or a placebo with maltodextrin. The study lasts 30 days, with supplementation taken daily. There are three study visits screening, baseline Day 0, and Day 30, during which various physical and biochemical tests are performed. Participants will complete questionnaires on recovery, mood, energy, fatigue, and quality of life at baseline and the end of the study. Physical assessments include VO2 max test, time-to-exhaustion, handgrip strength, and isometric mid-thigh pull. Blood tests will measure circulating nitratesnitrites, circulatory efficiency, and lactate kinetics. Side effects and adverse events will be monitored throughout the study to ensure safety.

CONDITIONS

Brief Title

A Trial to Study the Effects of Ginseng and Cordyceps on Aerobic Capacity, Lactate Kinetics, and Nitric Oxide

Research Team

M

Michael Michael La Monica, Ph.D., CSCS

T

Tim N Ziegenfuss, PhD, CSCS, FISSN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here